Pharmaceuticals policy: GK, General Studies and Current Affairs

India joins the Global Antimicrobial Resistance Research and Development Hub

The Department of Biotechnology, Ministry of Science & Technology has announced the membership of India into Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub. Antimicrobial Resistance Antimicrobial Resistance is the ability of a microbe to resist the effects of medication that once could successfully treat the microbe. The emergence and spread of antimicrobial resistance ..

Rajasthan ranked 1st in free medicine scheme implementation under National Health Mission

The flagship scheme of Rajasthan government has topped the 16-state chart detailing implementation of the free medicine scheme i.e. run under the National Health Mission (NHM). The NHM assessed the performance of the states on the basis of effective implementation of Drugs and Vaccine Distribution Management System (DVDMS), stock of essential drugs, value of drugs ..

Union Government bans Colistion in animal food industry

In a bid to preserve the drug’s efficacy in humans, the Ministry of Health and Family Welfare has banned the manufacture, sale and distribution of Colistin and its formulations for food-producing animals, poultry, aqua farming and animal feed supplements. The ban has been imposed under provisions of section 26A of the Drugs and Cosmetics Act ..

Indian scientists at CCMB discovers a new enzyme “Murein Endopeptidase” to break bacterial cell wall

Scientists at the Centre for Cellular & Molecular Biology (CCMB) have discovered a new enzyme ‘Murein Endopeptidase’ which helps in breaking cell walls of bacteria. This discovery offers a potential for a new drug delivery route to arrest the anti-bacterial resistance through existing antibiotic drugs. Hence, it opens up fresh ways to target microbes, leading ..

New Delhi headquarters of National Pharmaceutical Pricing Authority (NPPA)

Recently, National drug pricing regulator NPPA has fixed the retail prices of 36 formulations, including those used for treatment of cancer, diabetes, infections, asthma, seizures, inflammation and pain, among others. As per data available with NPPA, the MRP for 105 brands will be reduced up to 85% entailing minimum saving of Rs 105 crore to ..